ACCORDANCE OF CLINICAL AND INSTRUMENTAL PROFILE TO CYSTATIN C LEVEL IN PATIENTS WITH STAGE II HYPERTENSION AND FREQUENT EXTRASYSTOLE

Authors:

Abstract:

156 patients with essential arterial hypertension of the II stage were examined, 124 of them had frequent symptomatic extrasystoles: 74 – of supraventricular and 50 – of ventricular origin. Another 32 patients had no arrhythmias and were a comparison group. The control group included 30 practically healthy normotensive persons. All patients underwent a complete clinical and laboratory and anthropometric examination, blood pressure measurement, daily blood pressure monitoring, daily electrocardiogram monitoring, echocardiography, and serum cystatin C determination. The value of glomerular filtration rate and the presence of paired ventricular extrasystole showed the greatest predicting level of serum cystatin C in patients with hypertension (OR 5.32 and 3.22, respectively, p<0.0001). It is proved that relatively high levels of cystatin C in patients with stage II hypertension are accompanied by the electrical instability of the left ventricular myocardium and can be considered as a marker of frequent and paired ventricular extrasystoles in these patients. Patients with hypertension with relatively high cystatin C are characterized by higher blood pressure, more severe structural remodelling of the left ventricle, and impaired renal function.

Keywords:

essential hypertension extrasystole cystatin C cystatin ratio cystatin background

References:

1. Chekalina N, Burmak Y, Petrov Y, Borisova Z, Manusha Y, Kazakov Y, et.al. Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease. Indian Heart J. 2018; 70 (5): 593-97. DOI: 10.1016/j.ihj.2018.04.006.
2. Dangle PP, Ayyash O, Kang А. Cystatin C-calculated glomerular filtration rate-a marker of early renal dysfunction in patients with neuropathic bladder. Urology. 2017; 100: 213–17. https://doi.org/10.1016/j.urology.2016.08.011
3. Filler G, Rodriguez Cuellar C, Medeiros M. Overcoming the limitations of glomerular filtration rate estimation by using a novel rapid bedside measurement? Ann Transl Med. 2018; 6 (15): 312. https://doi.org/10.21037/atm.2018.06.51
4. Іvankova АV, Кuzminova NV, Lozinsky SE, Іvanov VP. Comparative assessment of renal function by cystatin C level in patients with hypertension and extrasystole. 2020; Biomedical and biosocial anthropology 41: 11-17. https://doi.org/10.31393/bba41-2020-02
5. Kuzminova NV, Ivankova AV, Ivanov VP, Lozinsky SE. Diagnostic and prognostic value of cystatin C as an early marker of renal dysfunction in patients with cardiovascular pathology. 2018; Likarska sprava 7-8: 17-23. https://doi.org/10.31640/JVD.7-8.2018(3)
6. Jin S, Xu J, Shen G, Gu P. Predictive value of circulating cystatin C level in patients with acute coronary syndrome: a meta-analysis. Scand J Clin Lab Invest. 2021; 81 (1): 1–7. https://doi.org/10.1080/00365513.2020.1846212
7. Lee HC, Lin YH. The Pathogenic Role of Very Low-Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome. Int J Mol Sci. 2020; 21 (3): 891. https://doi.org/10.3390/ijms21030891
8. Parsi E, Bitterlich N, Winkelmann A, Rösler D, Metzner C. Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function. BMC Cardiovasc Disord. 2018; 18 (1): 220. https://doi.org/10.1186/s12872-018-0954-6
9. Pottel H, Delanaye P, Schaeffner E. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. 2017; Nephrol. Dial. Transplant. 32 (3): 497–507. https://doi.org/10.1093/ndt/gfw425
10. Sherief LM, Youssef DM, Sherbiny HS. Screening of renal dysfunction among Burkitt lymphoma survivors by novel markers. Hematology. 2017; 22 (5): 265–73. https://doi.org/10.1080/10245332.2016.1259713
11. Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR. et al. Cystatin C versus creatinine in determining risk based on kidney function. N. Engl J. Med. 2013; 369 (10): 932–43. https://doi.org/10.1056/NEJMoa1214234
12. Stevens PE, Levin A. Kidney Disease: Improving Global Outcomes (KDIGO) СKD Workgroup. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Ann. Intern. Med. 2013; 158 (11): 825–30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007
13. Sun Y, Lu Q, Cheng B, Tao X. Prognostic value of cystatin C in patients with acute coronary syndrome: A systematic review and meta-analysis. Eur. J. Clin. Invest. 2021; 51 (3): e13440. https://doi.org/10.1111/eci.13440
14. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D. [et al.] 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75: 1334–57. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
15. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M. [et al.] ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39 (33): 3021–3104. https://doi.org/10.1093/eurheartj/ehy339

Publication:

«World of Medicine and Biology» Vol. 18 No. 80 (2022) , с. 89-93
УДК 616.12-008.331.1: 616.12-07

DOI:

https://doi.org/10.26724/2079-8334-2022-2-80-89-93